Targeting GSK-3β enzyme by diazepino-quinolone derivatives
-
Published:2022-11-03
Issue:10
Volume:21
Page:2147-2151
-
ISSN:1596-9827
-
Container-title:Tropical Journal of Pharmaceutical Research
-
language:
-
Short-container-title:Trop. J. Pharm Res
Author:
Swellmeen Lubna,Basheer Haneen A,Uzrail Amal,Sallam Haneen,Al-Hiari Yusuf,Alkilani Ahlam
Abstract
Purpose: To synthesize a heterocyclic system containing quinolone and diazepine scaffolds as GSK-3β inhibitor.
Methods: The diazepino-quinoline derivatives were synthesized starting from quinolone nucleus in a simple chemical reaction. The in vitro GSK-3β enzyme assay and MTT assay against cancer cell lines were carried out followed by Z´ı-LYTE GSK-3β assay. Anticancer activity was determined using U-87 glioma cell line.
Results: Diazepino-quinoline derivatives were obtained in a good yield, and compound 102 exhibited significant activity against in vitro GSK-3β (IC50: 0.114 μM), and anticancer activity (IC50: 37 μM) against U-87 glioma cell line.
Conclusion: The GSK-3β enzyme is a potential target to treat different diseases, and diazepines derivatives are a successful template for inhibitors design against GSK-3β enzyme with IC50 in a micromolar range.
Publisher
African Journals Online (AJOL)
Subject
Pharmacology (medical),Pharmaceutical Science